Cargando…
Efficacy and Safety of Panax Notoginseng Saponins (Xueshuantong) in Patients With Acute Ischemic Stroke (EXPECT) Trial: Rationale and Design
Background: Although revascularization treatment is recommended as the first-line therapy for patients with non-minor acute ischemic stroke (AIS), it only benefits a minority of patients. Previous studies have reported the positive effects of Panax notoginseng saponins (PNS) (Xueshuantong lyophilize...
Autores principales: | Feng, Luda, Han, Fang, Zhou, Li, Wu, Shengxian, Du, Yawei, Zhang, Dandan, Zhang, Chi, Gao, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101545/ https://www.ncbi.nlm.nih.gov/pubmed/33967788 http://dx.doi.org/10.3389/fphar.2021.648921 |
Ejemplares similares
-
Efficacy and safety of Panax notoginseng saponins (Xuesaitong) for patients with acute ischemic stroke: a systematic review and meta-analysis of randomized controlled trials
por: Shi, Xinyi, et al.
Publicado: (2023) -
Stereoisomers of Saponins in Panax notoginseng (Sanqi): A Review
por: Peng, Ming, et al.
Publicado: (2018) -
Effect of Panax notoginseng Saponins and Major Anti-Obesity Components on Weight Loss
por: Zhang, Xuelian, et al.
Publicado: (2021) -
Efficacy and Safety of Panax notoginseng Saponins in the Treatment of Adults With Ischemic Stroke in China: A Randomized Clinical Trial
por: Wu, Longfei, et al.
Publicado: (2023) -
Panax notoginseng Saponins for Treating Coronary Artery Disease: A Functional and Mechanistic Overview
por: Duan, Lian, et al.
Publicado: (2017)